DE69940971D1 - Verwendung von erythropoietin zur behandlung von primärer hämochromatosen - Google Patents
Verwendung von erythropoietin zur behandlung von primärer hämochromatosenInfo
- Publication number
- DE69940971D1 DE69940971D1 DE69940971T DE69940971T DE69940971D1 DE 69940971 D1 DE69940971 D1 DE 69940971D1 DE 69940971 T DE69940971 T DE 69940971T DE 69940971 T DE69940971 T DE 69940971T DE 69940971 D1 DE69940971 D1 DE 69940971D1
- Authority
- DE
- Germany
- Prior art keywords
- hemo
- chromates
- erythropoietin
- primary
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102100038285 Endogenous retroviral envelope protein HEMO Human genes 0.000 title 1
- 102000003951 Erythropoietin Human genes 0.000 title 1
- 108090000394 Erythropoietin Proteins 0.000 title 1
- 101001033183 Homo sapiens Endogenous retroviral envelope protein HEMO Proteins 0.000 title 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 title 1
- 229940105423 erythropoietin Drugs 0.000 title 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1998116035 DE19816035A1 (de) | 1998-04-09 | 1998-04-09 | Verwendung von Erythropoietin zur Behandlung von Hämochromatosen |
| EP98250222A EP0965349A1 (de) | 1998-06-18 | 1998-06-18 | Verwendung von Erythropoietin zur Behandlung von Hämochromatosen |
| PCT/EP1999/002422 WO1999052542A1 (en) | 1998-04-09 | 1999-04-09 | Use of erythropoietin for the treatment of haemochromatoses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69940971D1 true DE69940971D1 (de) | 2009-07-23 |
Family
ID=26045400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69940971T Expired - Lifetime DE69940971D1 (de) | 1998-04-09 | 1999-04-09 | Verwendung von erythropoietin zur behandlung von primärer hämochromatosen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6676947B1 (de) |
| EP (1) | EP1085900B1 (de) |
| JP (1) | JP3930250B2 (de) |
| AR (1) | AR019025A1 (de) |
| AT (1) | ATE433323T1 (de) |
| AU (1) | AU3814599A (de) |
| DE (1) | DE69940971D1 (de) |
| DK (1) | DK1085900T3 (de) |
| ES (1) | ES2326501T3 (de) |
| WO (1) | WO1999052542A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004063927A1 (de) * | 2004-01-23 | 2005-12-15 | Epoplus Gmbh Co.Kg | Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden |
| US7588745B2 (en) * | 2004-04-13 | 2009-09-15 | Si Options, Llc | Silicon-containing products |
| KR100701422B1 (ko) * | 2004-07-29 | 2007-03-30 | 주식회사 하이닉스반도체 | 케미컬 어택을 방지할 수 있는 반도체소자 및 그 제조 방법 |
| US7714114B2 (en) | 2005-02-16 | 2010-05-11 | Nektar Therapeutics | Conjugates of an EPO moiety and a polymer |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
| MX2011000859A (es) | 2008-07-23 | 2011-02-24 | Ambrx Inc | Polipeptidos g-csf bovinos modificados y sus usos. |
| EA019653B1 (ru) | 2008-09-26 | 2014-05-30 | Амбркс Инк. | Модифицированные полипептиды эритропоэтина животных и их применение |
| EP2316334A1 (de) | 2009-10-22 | 2011-05-04 | Fresenius Medical Care Deutschland GmbH | Verfahren zur Beurteilung des Flüssigkeitszustands und/oder der Empfindlichkeit für eine Flüssigkeitsentfernung eines Patienten, Steuerung und Vorrichtungen |
| TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin |
| US5013718A (en) | 1986-11-21 | 1991-05-07 | Amgen, Inc. | Method for treating iron overload using EPO |
| DE3729863A1 (de) | 1987-09-05 | 1989-03-16 | Boehringer Mannheim Gmbh | Stabilisierte erythropoietin-lyophilisate |
| JP3414539B2 (ja) * | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
| WO1996039202A1 (en) * | 1995-06-06 | 1996-12-12 | Osteogenics Inc. | Biocompatible hydroxyapatite formulations and uses therefor |
| TW586933B (en) | 1996-06-20 | 2004-05-11 | Chugai Pharmaceutical Co Ltd | Compositions for treating liver-complaints using EPO |
| FI964138L (fi) | 1996-10-15 | 1998-04-16 | Nokia Telecommunications Oy | Kanavanvarausmenetelmä ja radiojärjestelmä |
-
1999
- 1999-04-06 AR ARP990101562A patent/AR019025A1/es unknown
- 1999-04-09 US US09/647,642 patent/US6676947B1/en not_active Expired - Lifetime
- 1999-04-09 AU AU38145/99A patent/AU3814599A/en not_active Abandoned
- 1999-04-09 ES ES99920626T patent/ES2326501T3/es not_active Expired - Lifetime
- 1999-04-09 DE DE69940971T patent/DE69940971D1/de not_active Expired - Lifetime
- 1999-04-09 JP JP2000543152A patent/JP3930250B2/ja not_active Expired - Lifetime
- 1999-04-09 AT AT99920626T patent/ATE433323T1/de active
- 1999-04-09 WO PCT/EP1999/002422 patent/WO1999052542A1/en active Application Filing
- 1999-04-09 EP EP99920626A patent/EP1085900B1/de not_active Expired - Lifetime
- 1999-04-09 DK DK99920626T patent/DK1085900T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JP3930250B2 (ja) | 2007-06-13 |
| ATE433323T1 (de) | 2009-06-15 |
| WO1999052542A1 (en) | 1999-10-21 |
| JP2002511418A (ja) | 2002-04-16 |
| DK1085900T3 (da) | 2009-08-10 |
| EP1085900A1 (de) | 2001-03-28 |
| AU3814599A (en) | 1999-11-01 |
| EP1085900B1 (de) | 2009-06-10 |
| AR019025A1 (es) | 2001-12-26 |
| ES2326501T3 (es) | 2009-10-13 |
| US6676947B1 (en) | 2004-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| ATE218355T1 (de) | Verwendung von mycobacterium zur tumorbehandlung | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE60038458D1 (de) | Verwendung von polymerem material zur behandlung harter oberflächen | |
| ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
| DE69940971D1 (de) | Verwendung von erythropoietin zur behandlung von primärer hämochromatosen | |
| DE69939723D1 (de) | Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
| DE69918541D1 (de) | Verwendung von nmda antagonisten zur behandlung des reizkolons | |
| DE69936449D1 (de) | Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen | |
| DE69408394D1 (de) | 4-Piperidino-piperidin zur Behandlung von Tumoren | |
| DE59104437D1 (de) | Verwendung von molybdänverbindungen zur lack-koagulierung. | |
| DE60021521D1 (de) | Isonipecotamide zur behandlung von integrin vermittelten störungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |